Background {#Sec1}
==========

The incidence of biliary tract pathology is growing due to the overall aging of the population worldwide, and this is particularly evident among the number of those over the age of 80^1^. Endoscopic Retrograde Cholangiopancreatography (ERCP) represents the gold standard exploratory technique for the treatment of biliary or pancreatic tract pathology, and it could be often performed with therapeutic intent by realizing procedures such as insertion of bile duct stents and/or endoscopic sphincterotomy. However, evidence about its safety in the elderly is still controversial.\[[@CR1]--[@CR5]\] A recent systematic review by Day et al.\[[@CR4]\] explored the issue of effectiveness and safety of ERCP in octogenarians (i.e. ≥80 years old) versus younger seniors and late adults, showing that perforation, hemorrhage, biliary infection, and other main complications of the procedure were not statistically different among the three groups. However, despite the sample size of the meta-analysis, patients did not undergo a comprehensive approach to be characterized. Instead of more inclusive tools, the frequency of symptoms, the proportion of some comorbid conditions (namely hypertension, diabetes, coronary heart and cerebrovascular diseases, and "others"), and the American Society of Anesthesiologists (ASA) physical status classification score were the parameters collected.\[[@CR6]\] From a geriatric perspective, the assessment of older patients is an interdisciplinary process that should include multiple domains, such as functional and nutritional status, cognition, accurate evaluation of comorbidity, and many others\[[@CR7]\].

In order to add knowledge to this scenario and to understand if this gap in patient's assessment applies to our population, we retrospectively analyzed the clinical records of older patients undergoing ERCP in the endoscopy unit of an Italian university hospital. Our aim was to assess how the specialists in endoscopy evaluate patients undergoing ERCP, the success rate of this procedure, and the incidence of complications in octogenarians compared to that of younger seniors (aged \< 80 years old).

Methods {#Sec2}
=======

Study design and subjects {#Sec3}
-------------------------

This retrospective observational single-center study was carried out at San Gerardo Hospital ASST Monza, a large Italian university hospital. We retrieved data from the Endoscopy Unit electronic registry, collecting all the ERCP procedures that took place from July 1st, 2013 to July 31st, 2015 in an electronic spreadsheet. We considered only ERCPs performed in patients ages 65 and older, and divided the study population into two groups according to the age criterion (65--79 vs. ≥80).

All data were de-identified according to the Italian legislation "Data Protection Code -- Legislative Decree no. 196/2003" (available at <http://www.garanteprivacy.it/home_en/italian-legislation>) for the protection of personal information. Permission for the use of this information was granted by a specific consent form signed by each patient or his/her legal representative for undergoing the endoscopy procedure. The informed consent forms are stored in the archive of San Gerardo Hospital ASST Monza (Monza, Italy).

For every ERCP procedure performed, we collected the following information: patient's age and gender, comorbid conditions, date, indication and duration of the procedure, ASA physical status classification score, \[[@CR6]\] duration of sedation/anesthesia, additional procedures, complications, success in addressing the indications, diagnosis, and whether the ERCP was completed or not. Multiple procedures performed in the same patient were also taken into account.

With more detail, the ASA score is a qualitative system originally developed to describe the pre-operative fitness of patients scheduled for surgical procedures. It currently consists of 6 classes, from ASA 1 (normal healthy subject) to ASA 6 (a declared brain-dead patient). The higher the ASA class, the poorer the patient's health status is considered to be. Comorbid conditions were assessed with the Charlson Comorbidity Index (CCI), \[[@CR8]\] a weighted index that assigns a different risk score (from 1 to 6) to 22 conditions and their related relative risk of 1-year mortality. The higher the CCI score, the higher the risk of 1-year mortality.

Procedures {#Sec4}
----------

All the ERCP procedures were performed by four experienced gastroenterologists with 10 or more years of expertise in endoscopy and in this procedure specifically.

Patients underwent sedation as indicated in our Endoscopy Unit sedation protocol, which agrees with national guidelines, available at: <http://www.sied.it/files/12ConigliaroFantiGIED3_14.pdf>; <http://www.sied.it/files/Lineeguidaperlasedazioneinendoscopiadigestiva.pdf> .

It should be considered that regulations limit the drugs that non-anesthetists could administer to meperidine or fentanest and midazolam. In ASA I and II patients who do not require a urgent procedure, the endoscopic team performed moderate sedation with opioids and midazolam. Sedation is constantly monitored as it is used for other endoscopic procedures.

ASA III/IV patients and those who need to undergo urgent ERCP were sedated and monitored by an anesthetist who decided to perform deep sedation or general anaesthesia according to its judgement and the subject's clinical conditions at the moment of undergoing the procedure. All urgent ERCPs were performed in the operating room irrespectively of the type of ERCP and sedation chosen.

Definition of complications {#Sec5}
---------------------------

The adverse events we recorded during and/or in response to ERCP procedures were defined as follows:

\- Pancreatitis: the onset of new abdominal pain with at least a three-fold elevation of serum amylase or lipase levels, at least 24 h after the procedure;

\- Perforation: retroperitoneal or bowel-wall perforation, as evidenced by imaging techniques;

\- Bleeding: clinical evidence of hemorrhage, with a decrease in hemoglobin \> 2 g/dL or the need for endoscopic or transfusion treatment;

\- Cholangitis: temperature of more than 38 °C for 24--48 h occurring after the procedure and thought to have a biliary cause, without evidence of concomitant infection;

\- Cardiopulmonary adverse events: myocardial infarction, cerebrovascular accident, congestive heart failure, cardiac/respiratory arrest, arrhythmia, hypoxemia (oxygen saturation \< 90%), hypotension (systolic blood pressure \< 90 mmHg), bradycardia (heart rate \< 60 beats/min), tachycardia (heart rate \> 110 beats/min), or vasovagal response, all of which were attributed to the performance of an ERCP procedure;

\- Mortality related/not related to the performance of the ERCP: death within 48 h after a procedure with complications or incomplete endoscopic treatment (for example, relief of bile duct obstruction was not achieved by the intervention) was regarded as a procedure-related death.

These complications were defined by Cotton's criteria \[[@CR9]\].

Outcomes {#Sec6}
--------

After describing the parameters and information we were able to collect from the hospital registry, the primary outcome was to assess the incidence of complications or deaths associated with ERCPs.

The secondary outcome was the identification of the baseline characteristics and ERCP-related variables able to predict the onset of complications.

Statistical analysis {#Sec7}
--------------------

All analyses were performed with the software SPSS Version 23.0 (IBM Corp., Armonk, NY, USA). Continuous variables were expressed as mean ± standard deviation (SD). Categorical variables were expressed as frequencies and percentages. Comparisons between the study groups were performed with the Student's t-test for continuous variables and the Chi-square test for categorical variables. All the comparisons were two-tailed.

The analyses of the risk factors for ERCP-related complications were performed through univariate and multivariate logistic regression models. Significance was obtained for values of *p* \< 0.05.

Results {#Sec8}
=======

Patients' characteristics {#Sec9}
-------------------------

Seven hundred and thirty-two ERCPs were performed at San Gerardo Hospital from July 1st 2013 to July 31st 2015. Of them, 485 (66.3%) were performed in patients ages 65--95. To date, 9% (33 subjects) of the population was nonagenarian (i.e. ≥90 years old). Four hundred and sixty-five patients were hospitalized at San Gerardo Hospital, while 20 subjects were admitted into other nearby hospitals but underwent ERCP in our Endoscopy unit; 53 ERCPs were considered as urgent procedures.

Ninety-seven patients underwent more than one procedure for technical reasons (e.g.: stent placement and removal) or for treatment of a second recurrence of a common bile duct (CBD) stone. Specifically, one patient underwent seven ERCPs, three patients underwent five ERPCs, eight patients underwent four ERCPs, 34 underwent three procedures, and 51 underwent ERCP twice.

Interestingly, the CCI was significantly higher in the younger group compared to that of the older group (Table [1](#Tab1){ref-type="table"}). However, considering the age-adjusted CCI, we observed the opposite situation with the CCI being higher in the older group than that of the younger one, but this difference did not reach statistical significance.Table 1Baseline characteristics of the enrolled patientsGroupsAge 65--79\
*N* = 280Age ≥ 80\
*N* = 185All\
*n* = 465*p*-valueMean age, years72.78 ± 4.485.29 ± 4.1877.6 ± 7.64\< 0.001Gender, n (%)\< 0.001 Male146 (52.1)66 (35.7)212 Female134 (47.9)119 (64.3)253Charlson Comorbidity Index (CCI), mean1.6 ± 2.01.2 ± 1.41.2 ± 1.80.008Age-adjusted CCI, mean4.4 ± 2.05.3 ± 7.04.8 ± 1.80.059ASA score, n0.048 I2 (0.7)--2 II210 (75.0)113 (61.1)323 III63 (22.5)69 (37.3)132 IV5 (1.8)3 (1.6)8 V------Urgent ERCP, n (%)27 (9.6)26 (14.1)53 (11.6)0.179Data are presented as mean ± SD or as a number and percentage. *ASA* American Society of Anesthesiologists

The ASA scores, considering each separate class, presented significant differences between the groups (*p* = 0.048). We also grouped the ASA scores between classes I-II (low intra-operative risk) and classes III-IV (moderate-to-high intra-operative risk), rather than all four classes individually, and we observed that the older group had a significantly greater proportion of class III-IV ASA scores (38.9% vs. 26.7% of the younger group, *p* = 0.011).

Table [2](#Tab2){ref-type="table"} shows that the main indication for ERCP intervention was CBD stones, followed by stent placement/removal. No statistical difference between the groups was found.Table 2Indications for ERCP procedures in the study groups and in the population as a wholeIndicationAge 65--79\
N = 280Age ≥ 80\
N = 185All\
*N* = 465CBD stones/ biliary colic92 (32.9)74 (40.0)166 (35.7)Stenosis51 (18.2)28 (15.1)79 (17.0)Acute Pancreatitis16 (5.7)12 (6.5)28 (6.0)Stent placement or removal66 (23.5)40 (21.6)106 (22.8)Cholangitis40 (14.3)29 (15.7)69 (14.8)Other15 (5.4)2 (1.1)17 (3.7)All indications are reported as a number and percentage (%)

### ERCP: Procedures, success rate and complications {#Sec10}

Among a total of 465 procedures, 438 were completed: 265 ERCPs belonged to the younger group, 173 to the older one. The rates of success of ERCP in the younger and older group were 94.6% and 93.7%, respectively.

The 27 failures were due to complications (3/27: 2 bradycardia and 1 perforation), single diverticulum associated ampulla (17/27), altered surgical anatomy (3/27), and multiple large diverticula with no identification of the Vater ampulla (4/27).

All procedures performed during the ERCP and the diagnoses are presented in Table [3](#Tab3){ref-type="table"} and Table [4](#Tab4){ref-type="table"}, respectively. No statistical differences between the groups were found. CBD stones were the most frequent diagnosis.Table 3Intra-ERCP procedures in the study groups and in the population as a whole. All procedures are reported as a number and percentage (%)ProceduresAge 65--79\
*N* = 280Age ≥ 80\
*N* = 185All\
*N* = 465Sphincterotomy, n %74 (28)47 (27)121 (27.6)Stent placement or removal, n %101 (38)65 (37.5)166 (37.9)Sphincterotomy and stent placement, n %85 (32)59 (34)144 (32.8)Other, n %5 (2)2 (1.5)7 (1.7)Incompleted procedure15 (5.3)12 (6.4)27 (5.8)Table 4ERCP diagnoses in the study groups and in the whole population. All diagnoses are. reported as number of patients and percentage (%)DiagnosisAge 65--79\
*N* = 265Age ≥ 80\
*N* = 173All\
*N* = 438CBD stones119 (44.9)87 (50.3)206 (47.0)Stenosis50 (18.9)31 (17.9)81 (18.5) Malignant stenosis40 (15.1%)31 (17.9%)71(16.2%) Inflammatory stenosis10 (3.8%)0Stent placement or removal73 (27.6)49 (28.3)122 (27.9)Other22 (8.3)6 (3.5)28 (6.4)*CBD* common bile duct

Fifty-three complications were related to the procedure (Table [5](#Tab5){ref-type="table"}). In the younger group, the complication rate was 13.2% vs. 10.0% in the older one.Table 5ERCP-related complicationsComplicationsAge 65--79Age ≥ 80AllCholangitis-Septic cholangitis17623Cardiopulmonary639Bleeding404Acute Pancreatitis549Perforation325Death ERCP related213Total ERCP-Related complications**371653**

All complications were higher in the younger group. Two out of 4 patients who had bleeding (younger group) used to take aspirin. To date, no one used oral anticoagulants.

Seven complications (13%) happened during urgent ERCPs, six in the younger group (four sepsis, two perforations), and one in the older group (sepsis). No statistical difference between these groups emerged.

Ten episodes were considered as not related to ERCP: fever without sepsis (eight patients), ischemic stroke (n = 1), and diarrhea (n = 1).

Nine patients died after the ERCP procedure, three of whom due to ERCP-related shock. Those cases underwent ERCP for CBD stones and for stent removal, and presented only cardiovascular comorbidities.

Six patients, of the nine who died, passed because of shock from septic cholangitis, despite successful completion of the ERCP. Their ages were 68, 69, 79, 89, 92, 93; three of these ERCPs were urgent procedures (performed in the patients aged 79, 89, and 92 years old).

In order to test the single variables in their potential association to the onset of complications, we performed univariate logistic regression analyses, but we did not find significant relationships with the outcome (Table [6](#Tab6){ref-type="table"}). Even the type of invasive procedure performed during ERCP was not related with experiencing complications. In particular, unsuccessful procedure (OR 1.45, *p* = 0.437), sphincterotomy (OR 1.14, *p* = 0.630), stenting (OR 0.62, *p* = 0.078), and the combination of sphincterotomy+stenting (OR 1.31, *p* = 0.303) did not relate to the outcome (Table [6](#Tab6){ref-type="table"}).Table 6Univariate logistic regression analysis of the potential predictors for the onset of ERCP-related complicationsPotential risk factorsOdds Ratio95% Confidence Interval*p*-valueAge (continuous)0.990.95--1.020.399Age group (≥80)0.670.40--1.120.128Sex, female0.810.50--1.320.390Charlson Comorbidity Index (CCI, continuous)0.960.83--1.100.547Age-adjusted CCI (continuous)0.930.81--1.060.260ASA score (continuous)1.030.64--1.660.901ASA group (III-IV)1.040.59--1.850.886Procedure not completed1.450,57--3.730.437Sphincterotomy1.140.66--1.970.630Stenting0.620.36--1.060.078Sphincterotomy + stent1.310.79--2.180.303Urgency of the procedure0.790.34--1.850.584*ASA* American Society of Anesthesiologists. ASA groups were separated into classes I-II vs. classes III-IV

We also performed a multivariate logistic regression analysis including age (groups of those \< 80 vs. those ≥80 years), gender, CCI (groups of those with scores of \< 4 vs. those with scores of ≥4), type of intervention (categorical), and urgency of the procedure. Not surprisingly, age, gender, type of procedure and urgency did not result as significantly associated with complications. However, the dichotomized CCI risk scores (in \< 4 versus ≥4) resulted as independently and significantly correlated with the outcome (Odds Ratio, OR = 0.29, 95% Confidence Interval, C.I.: 0.09--0.99, *p* = 0.049).

Discussion {#Sec11}
==========

The demand for ERCP is increasing in the elderly and it is important to know the procedure risks and benefits in older patients. The two study groups were different in terms of age, sex, CCI and ASA score.

The older group (ages 80 and above) had a significantly higher number of female patients and this is probably due to the different life expectancy between men and women. This data was recently confirmed in the literature \[[@CR10]\].

The older group showed a lower mean CCI, thus raising a question about the existence of a possible selection bias. However, if we consider the age-adjusted CCI, the mean values were significantly higher in older patients. In order to perform ERCP procedures, these data suggest that gastroenterologists specializing in endoscopy probably rely on inclusion criteria that do not take into account the multi-faceted characteristics of the geriatric patient. However, the CCI -- age-adjusted or not -- should not be considered as a stand-alone assessment tool. Those inclusion criteria often imply that older subjects are selected for their apparent "fitness" according to comorbidity, which is a crucial limitation. Even the ASA physical status classification system - despite being validated for assessing fitness of patients undergoing surgery - cannot be considered as a stand-alone tool for the evaluation of elderly subjects scheduled for ERCP. Not surprisingly, ASA score is mainly a qualitative rather than a quantitative index, theoretically insufficient to describe the complexity of the geriatric population.

A further possible signal of selection bias is the fact that ASA III-IV patients were significantly prevalent in the older group, in potential contrast with the simultaneous presence of a lower index of comorbidity in this age group. Again, even by dichotomizing the CCI in \< 4 versus ≥4, the younger group displays a higher number of patients with CCI ≥ 4 than the older one, confirming that patients scheduled for ERCP undergo uneven selection criteria. Those criteria tend to exclude the more comorbid elderly subjects from the procedure, presumably according to the assumption that higher comorbidity translates into higher incidence of complications and mortality related to this procedure.

We agree that several older patients are able to tolerate ERCP, and that older people with comorbidities are at higher risk for some complications compared to those without comorbid conditions,\[[@CR11]\] but understanding the "big picture" goes beyond the mere collection of medical history or fitness status. When facing older individuals, a comprehensive geriatric assessment (CGA) should be considered as the preferable way to assess their health status in its entirety. The CGA considers the multiple aspects of the elderly, namely comorbid conditions, polypharmacy, functional level, cognition, and nutritional status among other factors which once combined provide a more reliable prognostic estimation than the ASA score or a comorbidity index alone. We are confident that the role of a CGA will be increasingly relevant for risk stratification and risk management of these patients, or at the very least, a useful guide for avoiding ERCP in subjects who have a high risk of experiencing more harm than benefits from the procedure.

Back to our findings in this study, they were consistent with the literature in terms of indications, diagnoses,\[[@CR1], [@CR10]\] and success rates (92.8% vs. 93.5%, for the younger and older group, respectively) \[[@CR12]--[@CR15]\]. The frequencies of ERCP-related complications were 13.2% in the young group and 10.0% in the older, which is slightly higher than the rates reported in the literature (2.5% to 12%). ERCP-related death incidence was 0.7% and 0.5% respectively, in line with previous reports, \[[@CR12]--[@CR25]\] though the only systematic review of ERCPs in the elderly suggests higher rates of death in octogenarians and nonagenarians than in younger patients.\[[@CR4]\] We also observed that advancing age was not related to complications, neither in the case of the continuous variable, nor the dichotomized one (OR = 0.99, 95% C.I.: 0.95--1.02, *p* = 0.399; and OR 0.67, 95% C.I. 0.40--1.12, *p* = 0.128, respectively). This is in line with our hypothesis, i.e. that age per se does not carry more complications. However, the finding should still be interpreted carefully because of several limitations.

Neither the indications (given a priori) nor the diagnoses (given *ex-post*, during or after ERCP completion) resulted as significantly related to complications, and again this could be due to the above-mentioned selection bias. Unexpectedly, the type of invasive procedure performed during ERCP was not related with experiencing complications (Table [6](#Tab6){ref-type="table"}).

Pertaining to the multivariate analysis, it should be noted that the sign of the relationship between CCI (dichotomized between \< 4 vs. ≥4) and complications is negative, thus it seems that the higher the CCI class, the lower the risk of complications. This fact does not agree with the literature, but it should be interpreted. Indeed, Table [1](#Tab1){ref-type="table"} showed that a higher number of patients with CCI ≥ 4 belong to the 70--79 age group, and that they do not experience more complications than the older group, opening various interpretations but also confirming the potential impact of the selection bias for this procedure. However, the literature findings do not agree in terms of risk factors for the onset of complications \[[@CR12]--[@CR16]\].

The first limitation of our study is represented by the relatively limited sample size (*n* = 363), though this is similar to that of other studies \[[@CR3], [@CR23], [@CR26]\]. The size issue probably explains also part of the difference between findings in the literature. This also gives a possible reason for the absence of significant associations observed at the univariate and multivariate analyses. On the one hand, this is quite unexpected because some of them should be theoretically correlated with complications, e.g. the degree of invasiveness of the procedure (performing sphincterotomy+stent placement is different than an ERCP executed for diagnostic purposes only). On the other hand, those results could be due to the selection bias for this procedure, which is expected to alter the normal correlations, especially if the study population is somewhat limited in size.

In addition, due to the single-centered and retrospective design, our findings cannot be generalized to other acute care settings. Furthermore, we retrieved hospital records but we do not have information about the post-discharge phases of care of the studied ERCP-treated patients. Finally, a major limitation is the lack of a structured, homogenous assessment of the ERCP candidates pre-operatively, which translates to the selection bias enlightened by our analysis. The only study that tried to assess the ERCP-related risk in the elderly population considering multiple domains suggested to include the Duke Activity Status Index (DASI, ranging from 0 to 58.2) to evaluate the functional capacity of subjects with cardiovascular disorders, with higher scores indicating better functional status. Further studies are necessary to confirm the importance of multidimensional scores, i.e. one or more tools able to describe the older patient comprehensively \[[@CR26]\].

Given these limitations, this study provides insight and paves the path for including more comprehensive assessment tools in future prospective investigations, which are strongly needed. The final objective is to better characterize the elderly patients pre-operatively and select candidates who will have the highest probability of benefiting from ERCP, reducing the risk of developing intra- and post-operative complications.

Conclusions {#Sec12}
===========

ERCP remains a procedure burdened by many known risks, especially if performed with urgency and in the elderly. Similar to many countries worldwide, the Italian population is progressively aging, \[[@CR27]\] and the absolute number of older people that will need ERCP procedures specifically in the future will increase. The possible implementation of a user-friendly and rapid tool for older patients' assessment will benefit both health professionals as well as their patients, reducing selection biases and improving their risk management. This will potentially and ultimately contribute to contain the incidence of post-ERCP complications and to test the real impact on the patient when the procedure is performed at an advanced age.
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